The Christie NHS FT Annual Report & Accounts 2019-20

The Christie NHS Foundation Trust Annual Report & Accounts 2019-10

includes a dedicated late effects clinic supported by expert nursing, psychological and medical staff. The service receives referrals from across the North West and offers a range of treatments including psychological support, medical treatments and surgery. The service is one of the pioneers of infrapubic penile prosthesis in the United Kingdom which enables patients to leave hospital earlier with an improved recovery profile and earlier resumption of sexual activity. Research The academic credentials of the urology research team are internationally renowned: encompassing FASTMAN prostate centre, a long history of laboratory and clinical research and leading one of the world’s largest prostate cancer trials (stampede). The team are also are urogenital cancer leaders within the European Reference Network eUROGEN and are recognised in research within rare cancers. Gynaecological Surgical Service Established in December 2014, The Christie gynae oncology multidisciplinary team now works as a single service provider with St Mary’s, Manchester Foundation Trust to provide the biggest Gynae Oncology service in the UK, to the entire population of Greater Manchester and East Cheshire. The gynae-oncology team provide surgical management to patients with endometrial, ovarian, cervical, vulval, vaginal and other rarer gynaecological cancers. As well as providing high quality traditional gynaecological surgery, the team employs a range of techniques and cutting edge technologies including robotic and laparoscopic surgery, sentinel lymph node technology and electro-chemoradiotherapy. The team has an established track record in providing enhanced recovery, fertility sparing surgery and exenterative surgery. With surgical colleagues from urology, colorectal and plastics,

reconstruction) for patients with suspected or diagnosed penile cancer. The service offers the full range of penile cancer treatments including the latest up to date penile sparing and reconstructive techniques. It is one of only two centres in the country that offers keyhole surgery for groin node dissection (known as Video-Endoscopic Inguinal Lymph Node Dissection or VEILND). Prostate The prostate cancer service is the largest and most advanced in the North West of England. The impending centralisation of prostate surgery centred on The Christie will make this one of the largest in the United Kingdom, offering real benefits in terms of patient outcomes, standardisation of care and access to trials and research. The team is recognised as a national training centre for robotic prostatectomy surgery. Renal The Christie continues to provide robotic assisted nephron sparing surgery for renal cancer for the majority of the city whilst the reconfiguration process continues. Testis and Sarcoma The Christie Urology team provides the supra regional service for testis cancer surgery including testis preserving, and retroperitoneal lymph node dissection (RPLND). The team are looking to develop robotic retroperitoneal lymph node dissection, making it one of only a few centres worldwide to offer this. To support this, the team has recruited a new consultant colleague to meet this challenge alongside the two other existing consultants. The soft tissue sarcoma service encompasses surgery for abdominal, pelvic and retroperitoneal sarcomas. Late effects The late effects service provides support to men suffering with side effects of their cancer treatment in relation to sexual dysfunction. This

13